TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs168403
log Bayes Factor = 5.27539
Chromosome 5   position 40,257,771  (GRCh37) Explore rs168403 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D12 Benign neoplasm of colon, rectum, anus and anal canal
1.000 0.000 0.000
D12.2 Ascending colon
0.999 0.001 0.000
D12.5 Sigmoid colon
0.999 0.001 0.000
D12.3 Transverse colon
0.994 0.006 0.000
D12.4 Descending colon
0.989 0.011 0.000
D12.0 Caecum
0.982 0.018 0.000
D12.1 Appendix
0.884 0.116 0.000
D12.8 Rectum
0.846 0.154 0.000
D12.6 Colon, unspecified
0.672 0.328 0.000
D12.9 Anus and anal canal
0.404 0.596 0.000
D12.7 Rectosigmoid junction
0.353 0.647 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.223 0.777 0.000
C01 Malignant neoplasm of base of tongue
0.214 0.786 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.212 0.788 0.000
C10 Malignant neoplasm of oropharynx
0.203 0.797 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.200 0.800 0.000
C09 Malignant neoplasm of tonsil
0.200 0.800 0.000
C04 Malignant neoplasm of floor of mouth
0.200 0.800 0.000
C02.9 Tongue, unspecified
0.198 0.802 0.000
C10.9 Oropharynx, unspecified
0.189 0.811 0.000
C07 Malignant neoplasm of parotid gland
0.185 0.815 0.000
C09.9 Tonsil, unspecified
0.182 0.818 0.000
C14.0 Pharynx, unspecified
0.174 0.826 0.000
C11 Malignant neoplasm of nasopharynx
0.170 0.830 0.000
C04.9 Floor of mouth, unspecified
0.170 0.830 0.000
C04.0 Anterior floor of mouth
0.170 0.830 0.000
C12 Malignant neoplasm of pyriform sinus
0.168 0.832 0.000
C02.1 Border of tongue
0.166 0.834 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.166 0.834 0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx
0.165 0.835 0.000
C02.2 Ventral surface of tongue
0.165 0.835 0.000
C05 Malignant neoplasm of palate
0.164 0.836 0.000
C02.4 Lingual tonsil
0.159 0.841 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.158 0.841 0.000
C02.8 Overlapping lesion of tongue
0.152 0.847 0.000
C02.3 Anterior two-thirds of tongue, part unspecified
0.152 0.847 0.000
C02.0 Dorsal surface of tongue
0.152 0.847 0.000
C03 Malignant neoplasm of gum
0.152 0.848 0.000
C09.0 Tonsillar fossa
0.150 0.850 0.000
C10.8 Overlapping lesion of oropharynx
0.146 0.854 0.000
C10.4 Branchial cleft
0.146 0.854 0.000
C10.3 Posterior wall of oropharynx
0.146 0.854 0.000
C10.2 Lateral wall of oropharynx
0.146 0.854 0.000
C10.1 Anterior surface of epiglottis
0.146 0.854 0.000
C10.0 Vallecula
0.146 0.854 0.000
C14.2 Waldeyer's ring
0.144 0.856 0.000
C09.8 Overlapping lesion of tonsil
0.144 0.856 0.000
C09.1 Tonsillar pillar (anterior) (posterior)
0.144 0.856 0.000
C04.8 Overlapping lesion of floor of mouth
0.144 0.856 0.000
C04.1 Lateral floor of mouth
0.144 0.856 0.000
C06.2 Retromolar area
0.140 0.859 0.000
C05.9 Palate, unspecified
0.139 0.861 0.000
C13 Malignant neoplasm of hypopharynx
0.134 0.866 0.000
C11.9 Nasopharynx, unspecified
0.132 0.868 0.000
C00 Malignant neoplasm of lip
0.124 0.876 0.000
C08.9 Major salivary gland, unspecified
0.123 0.877 0.000
C11.8 Overlapping lesion of nasopharynx
0.122 0.878 0.000
C11.3 Anterior wall of nasopharynx
0.122 0.878 0.000
C11.2 Lateral wall of nasopharynx
0.122 0.878 0.000
C11.1 Posterior wall of nasopharynx
0.122 0.878 0.000
C11.0 Superior wall of nasopharynx
0.122 0.878 0.000
C06.9 Mouth, unspecified
0.120 0.880 0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth
0.119 0.881 0.000
C06.1 Vestibule of mouth
0.119 0.881 0.000
C05.8 Overlapping lesion of palate
0.118 0.882 0.000
C05.2 Uvula
0.118 0.882 0.000
C08.8 Overlapping lesion of major salivary glands
0.114 0.886 0.000
C08.1 Sublingual gland
0.114 0.886 0.000
C03.9 Gum, unspecified
0.109 0.891 0.000
C03.0 Upper gum
0.109 0.891 0.000
C05.0 Hard palate
0.108 0.891 0.000
C03.1 Lower gum
0.101 0.899 0.000
C08.0 Submandibular gland
0.100 0.900 0.000
C05.1 Soft palate
0.099 0.901 0.000
C13.8 Overlapping lesion of hypopharynx
0.096 0.904 0.000
C13.2 Posterior wall of hypopharynx
0.096 0.904 0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect
0.096 0.904 0.000
C06.0 Cheek mucosa
0.090 0.910 0.000
C00.8 Overlapping lesion of lip
0.089 0.911 0.000
C00.6 Commissure of lip
0.089 0.911 0.000
C00.5 Lip, unspecified, inner aspect
0.089 0.911 0.000
C00.4 Lower lip, inner aspect
0.089 0.911 0.000
C00.3 Upper lip, inner aspect
0.089 0.911 0.000
C00.2 External lip, unspecified
0.089 0.911 0.000
C13.0 Postcricoid region
0.088 0.912 0.000
H52.2 Astigmatism
0.000 0.913 0.087
H52 Disorders of refraction and accommodation
0.000 0.916 0.084
C00.9 Lip, unspecified
0.082 0.918 0.000
C00.1 External lower lip
0.082 0.918 0.000
H52.1 Myopia
0.000 0.918 0.082
C13.9 Hypopharynx, unspecified
0.080 0.919 0.000
C00.0 External upper lip
0.074 0.925 0.000
H52.0 Hypermetropia
0.000 0.926 0.074
H52.3 Anisometropia and aniseikonia
0.000 0.931 0.069
H52.7 Disorder of refraction, unspecified
0.000 0.937 0.063
H52.6 Other disorders of refraction
0.000 0.939 0.060
H52.5 Disorders of accommodation
0.000 0.939 0.060
H52.4 Presbyopia
0.000 0.952 0.047
T50.9 Other and unspecified drugs, medicaments and biological substances
0.035 0.965 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.031 0.969 0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction
0.000 0.970 0.030
T46 Poisoning by agents primarily affecting the cardiovascular system
0.028 0.972 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.027 0.973 0.000
H49 Paralytic strabismus
0.000 0.973 0.027
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.026 0.974 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.026 0.974 0.000
T50.8 Diagnostic agents
0.025 0.975 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.024 0.976 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.024 0.976 0.000
H49.1 Fourth [trochlear] nerve palsy
0.000 0.977 0.023
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.023 0.977 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.023 0.977 0.000
H49.0 Third [oculomotor] nerve palsy
0.000 0.977 0.023
T50.1 Loop [high-ceiling] diuretics
0.023 0.977 0.000
T50.7 Analeptics and opioid receptor antagonists
0.023 0.977 0.000
T50.5 Appetite depressants
0.023 0.977 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.023 0.977 0.000
T50.0 Mineralocorticoids and their antagonists
0.023 0.977 0.000
K63.5 Polyp of colon
0.023 0.977 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.022 0.978 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.022 0.978 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.022 0.978 0.000
H49.9 Paralytic strabismus, unspecified
0.000 0.979 0.021
T36 Poisoning by systemic antibiotics
0.021 0.979 0.000
T50.4 Drugs affecting uric acid metabolism
0.021 0.979 0.000
H51 Other disorders of binocular movement
0.000 0.979 0.021
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.020 0.979 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.020 0.980 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.020 0.980 0.000
T46.1 Calcium-channel blockers
0.020 0.980 0.000
T43.6 Psychostimulants with abuse potential
0.020 0.980 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.020 0.980 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.020 0.980 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.020 0.980 0.000
T46.7 Peripheral vasodilators
0.020 0.980 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.020 0.980 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.020 0.980 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.020 0.980 0.000
H49.4 Progressive external ophthalmoplegia
0.000 0.980 0.019
H49.3 Total (external) ophthalmoplegia
0.000 0.981 0.019
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.019 0.981 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.019 0.981 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.019 0.981 0.000
K70.9 Alcoholic liver disease, unspecified
0.000 0.981 0.019
T38.1 Thyroid hormones and substitutes
0.019 0.981 0.000
T45.2 Vitamins, not elsewhere classified
0.019 0.981 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.018 0.982 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.018 0.982 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.018 0.982 0.000
T43.2 Other and unspecified antidepressants
0.018 0.982 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.017 0.982 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.017 0.982 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.017 0.982 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.017 0.982 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.017 0.982 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.017 0.982 0.000
T44.0 Anticholinesterase agents
0.017 0.982 0.000
H49.2 Sixth [abducent] nerve palsy
0.000 0.983 0.017
T45.0 Antiallergic and antiemetic drugs
0.017 0.983 0.000
T48.5 Anti-common-cold drugs
0.017 0.983 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.017 0.983 0.000
T38.0 Glucocorticoids and synthetic analogues
0.017 0.983 0.000
H49.8 Other paralytic strabismus
0.000 0.983 0.017
T43.0 Tricyclic and tetracyclic antidepressants
0.017 0.983 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.017 0.983 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.017 0.983 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.017 0.983 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.017 0.983 0.000
T38.5 Other oestrogens and progestogens
0.016 0.983 0.000
T36.8 Other systemic antibiotics
0.016 0.983 0.000
N39.3 Stress incontinence
0.000 0.984 0.016
T43.9 Psychotropic drug, unspecified
0.016 0.984 0.000
T36.4 Tetracyclines
0.016 0.984 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.016 0.984 0.000
T48.4 Expectorants
0.016 0.984 0.000
T48.3 Antitussives
0.016 0.984 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.016 0.984 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.016 0.984 0.000
T48.0 Oxytocic drugs
0.016 0.984 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.016 0.984 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.016 0.984 0.000
T45.8 Other primarily systemic and haematological agents
0.016 0.984 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.016 0.984 0.000
T45.6 Fibrinolysis-affecting drugs
0.016 0.984 0.000
T45.4 Iron and its compounds
0.016 0.984 0.000
T45.3 Enzymes, not elsewhere classified
0.016 0.984 0.000
T38.9 Other and unspecified hormone antagonists
0.016 0.984 0.000
T38.7 Androgens and anabolic congeners
0.016 0.984 0.000
T38.4 Oral contraceptives
0.016 0.984 0.000
T38.2 Antithyroid drugs
0.016 0.984 0.000
T47.2 Stimulant laxatives
0.015 0.984 0.000
T47.6 Antidiarrhoeal drugs
0.015 0.984 0.000
T36.0 Penicillins
0.015 0.985 0.000
T36.9 Systemic antibiotic, unspecified
0.015 0.985 0.000
T36.7 Antifungal antibiotics, systemically used
0.015 0.985 0.000
T36.6 Rifamycins
0.015 0.985 0.000
T36.5 Aminoglycosides
0.015 0.985 0.000
T36.2 Chloramphenicol group
0.015 0.985 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.015 0.985 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.015 0.985 0.000
H51.8 Other specified disorders of binocular movement
0.000 0.985 0.015
H51.1 Convergence insufficiency and excess
0.000 0.985 0.015
H51.0 Palsy of conjugate gaze
0.000 0.985 0.015
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.015 0.985 0.000
T37.5 Antiviral drugs
0.015 0.985 0.000
T37.4 Anthelminthics
0.015 0.985 0.000
T37.3 Other antiprotozoal drugs
0.015 0.985 0.000
T37.1 Antimycobacterial drugs
0.015 0.985 0.000
T37.0 Sulphonamides
0.015 0.985 0.000
T47.4 Other laxatives
0.015 0.985 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.015 0.985 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.015 0.985 0.000
T47.7 Emetics
0.015 0.985 0.000
T47.5 Digestants
0.015 0.985 0.000
T47.3 Saline and osmotic laxatives
0.015 0.985 0.000
T47.0 Histamine H(2)-receptor antagonists
0.015 0.985 0.000
H51.2 Internuclear ophthalmoplegia
0.000 0.985 0.015
T36.3 Macrolides
0.015 0.985 0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm
0.015 0.985 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.014 0.986 0.000
T41.5 Therapeutic gases
0.014 0.986 0.000
T41.4 Anaesthetic, unspecified
0.014 0.986 0.000
T41.3 Local anaesthetics
0.014 0.986 0.000
T41.2 Other and unspecified general anaesthetics
0.014 0.986 0.000
T41.1 Intravenous anaesthetics
0.014 0.986 0.000
T41.0 Inhaled anaesthetics
0.014 0.986 0.000
H51.9 Disorder of binocular movement, unspecified
0.000 0.986 0.014
T49.9 Topical agent, unspecified
0.014 0.986 0.000
T49.8 Other topical agents
0.014 0.986 0.000
T49.7 Dental drugs, topically applied
0.014 0.986 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.014 0.986 0.000
T49.5 Ophthalmological drugs and preparations
0.014 0.986 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.014 0.986 0.000
T49.3 Emollients, demulcents and protectants
0.014 0.986 0.000
T49.2 Local astringents and local detergents
0.014 0.986 0.000
T49.1 Antipruritics
0.014 0.986 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.014 0.986 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.013 0.986 0.000
K70 Alcoholic liver disease
0.000 0.988 0.012
T45.5 Anticoagulants
0.011 0.988 0.000
K70.1 Alcoholic hepatitis
0.000 0.989 0.011
T43.5 Other and unspecified antipsychotics and neuroleptics
0.011 0.989 0.000
D23.3 Skin of other and unspecified parts of face
0.000 0.989 0.011
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.010 0.989 0.000
K70.0 Alcoholic fatty liver
0.000 0.990 0.010
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.010 0.990 0.000
Z48.9 Surgical follow-up care, unspecified
0.010 0.990 0.000
H50 Other strabismus
0.000 0.990 0.010
K70.4 Alcoholic hepatic failure
0.000 0.990 0.010
N05.2 Diffuse membranous glomerulonephritis
0.009 0.991 0.000
H50.8 Other specified strabismus
0.000 0.991 0.009
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.991 0.009
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.009 0.991 0.000
H50.4 Other and unspecified heterotropia
0.000 0.992 0.008
N05.1 Focal and segmental glomerular lesions
0.008 0.992 0.000
N05 Unspecified nephritic syndrome
0.008 0.992 0.000
K29.0 Acute haemorrhagic gastritis
0.008 0.992 0.000
M13.95 Arthritis, unspecified (Pelvic region and thigh)
0.000 0.992 0.008
H50.2 Vertical strabismus
0.000 0.992 0.008
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.008 0.992 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.007 0.992 0.000
T40.8 Lysergide [LSD]
0.007 0.992 0.000
T40.7 Cannabis (derivatives)
0.007 0.992 0.000
T40.3 Methadone
0.007 0.992 0.000
T40.0 Opium
0.007 0.992 0.000
H50.5 Heterophoria
0.000 0.992 0.007
H50.3 Intermittent heterotropia
0.000 0.992 0.007
T40.4 Other synthetic narcotics
0.007 0.993 0.000
T40.6 Other and unspecified narcotics
0.007 0.993 0.000
T40.5 Cocaine
0.007 0.993 0.000
T40.1 Heroin
0.007 0.993 0.000
H50.6 Mechanical strabismus
0.000 0.993 0.007
N05.7 Diffuse crescentic glomerulonephritis
0.007 0.993 0.000
T42.0 Hydantoin derivatives
0.007 0.993 0.000
N05.8 Other
0.006 0.994 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.994 0.000
S51.0 Open wound of elbow
0.006 0.994 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.006 0.994 0.000
T42.3 Barbiturates
0.006 0.994 0.000
T42.2 Succinimides and oxazolidinediones
0.006 0.994 0.000
N05.9 Unspecified
0.006 0.994 0.000
N05.6 Dense deposit disease
0.006 0.994 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.994 0.000
N05.0 Minor glomerular abnormality
0.006 0.994 0.000
R70.0 Elevated erythrocyte sedimentation rate
0.006 0.994 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.994 0.000
C45.9 Mesothelioma, unspecified
0.006 0.994 0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)
0.005 0.995 0.000
N83.1 Corpus luteum cyst
0.005 0.995 0.000
E83.5 Disorders of calcium metabolism
0.005 0.995 0.000
T42.1 Iminostilbenes
0.005 0.995 0.000
G12.2 Motor neuron disease
0.000 0.995 0.005
K70.3 Alcoholic cirrhosis of liver
0.000 0.995 0.005
M79.62 Pain in limb (Upper arm)
0.000 0.996 0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.004 0.996 0.000
C45 Mesothelioma
0.004 0.996 0.000
T78.2 Anaphylactic shock, unspecified
0.004 0.996 0.000
R01.1 Cardiac murmur, unspecified
0.000 0.996 0.004
K76.0 Fatty (change of) liver, not elsewhere classified
0.000 0.996 0.004
G11.9 Hereditary ataxia, unspecified
0.000 0.996 0.004
H50.0 Convergent concomitant strabismus
0.000 0.996 0.004
G11 Hereditary ataxia
0.000 0.996 0.004
H43.1 Vitreous haemorrhage
0.000 0.996 0.004
G12 Spinal muscular atrophy and related syndromes
0.000 0.996 0.004
C45.0 Mesothelioma of pleura
0.004 0.996 0.000
C45.7 Mesothelioma of other sites
0.004 0.996 0.000
G11.4 Hereditary spastic paraplegia
0.000 0.996 0.004
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.004 0.996 0.000
M23.49 Loose body in knee-Unspec lig/men
0.004 0.996 0.000
T42.4 Benzodiazepines
0.004 0.996 0.000
R32 Unspecified urinary incontinence
0.000 0.996 0.004
E21.3 Hyperparathyroidism, unspecified
0.003 0.997 0.000
G11.1 Early-onset cerebellar ataxia
0.000 0.997 0.003
C45.2 Mesothelioma of pericardium
0.003 0.997 0.000
C45.1 Mesothelioma of peritoneum
0.003 0.997 0.000
N70.9 Salpingitis and oophoritis, unspecified
0.003 0.997 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.000 0.997 0.003
G11.8 Other hereditary ataxias
0.000 0.997 0.003
G11.3 Cerebellar ataxia with defective DNA repair
0.000 0.997 0.003
G11.2 Late-onset cerebellar ataxia
0.000 0.997 0.003
G11.0 Congenital nonprogressive ataxia
0.000 0.997 0.003
H71 Cholesteatoma of middle ear
0.003 0.997 0.000
G12.9 Spinal muscular atrophy, unspecified
0.000 0.997 0.003
G12.8 Other spinal muscular atrophies and related syndromes
0.000 0.997 0.003
G12.1 Other inherited spinal muscular atrophy
0.000 0.997 0.003
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
0.000 0.997 0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.003 0.997 0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities
0.000 0.997 0.003
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
0.003 0.997 0.000
T91.8 Sequelae of other specified injuries of neck and trunk
0.003 0.997 0.000
T39.4 Antirheumatics, not elsewhere classified
0.003 0.997 0.000
T39.2 Pyrazolone derivatives
0.003 0.997 0.000
E26.0 Primary hyperaldosteronism
0.003 0.997 0.000
H47.0 Disorders of optic nerve, not elsewhere classified
0.003 0.997 0.000
G10 Huntington's disease
0.000 0.997 0.003
R25.8 Other and unspecified abnormal involuntary movements
0.003 0.997 0.000
R25.2 Cramp and spasm
0.003 0.997 0.000
X78.0 Home
0.003 0.997 0.000
H47 Other disorders of optic [2nd] nerve and visual pathways
0.003 0.997 0.000
R70.1 Abnormal plasma viscosity
0.003 0.997 0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
0.000 0.997 0.002
M54.36 Sciatica (Lumbar region)
0.003 0.997 0.000
H47.2 Optic atrophy
0.003 0.997 0.000
D10.3 Other and unspecified parts of mouth
0.000 0.997 0.003
T39.0 Salicylates
0.003 0.997 0.000
E26 Hyperaldosteronism
0.003 0.997 0.000
E34 Other endocrine disorders
0.003 0.997 0.000
E34.8 Other specified endocrine disorders
0.002 0.997 0.000
H43.3 Other vitreous opacities
0.000 0.997 0.002
F05.9 Delirium, unspecified
0.002 0.998 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.002 0.998 0.000
H50.9 Strabismus, unspecified
0.002 0.998 0.001
H47.3 Other disorders of optic disk
0.002 0.998 0.000
H50.1 Divergent concomitant strabismus
0.000 0.998 0.002
D03.6 Melanoma in situ of upper limb, including shoulder
0.000 0.998 0.002
H43 Disorders of vitreous body
0.000 0.998 0.002
K76.7 Hepatorenal syndrome
0.000 0.998 0.002
E34.9 Endocrine disorder, unspecified
0.002 0.998 0.000
E34.0 Carcinoid syndrome
0.002 0.998 0.000
E23 Hypofunction and other disorders of pituitary gland
0.002 0.998 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.002 0.998 0.000
F05 Delirium, not induced by alcohol and other psychoactive substances
0.002 0.998 0.000
G14 Postpolio syndrome
0.000 0.998 0.002
E26.9 Hyperaldosteronism, unspecified
0.002 0.998 0.000
E23.0 Hypopituitarism
0.002 0.998 0.000
H47.1 Papilloedema, unspecified
0.002 0.998 0.000
S51 Open wound of forearm
0.002 0.998 0.000
E23.7 Disorder of pituitary gland, unspecified
0.002 0.998 0.000
F05.8 Other delirium
0.002 0.998 0.000
H47.7 Disorder of visual pathways, unspecified
0.002 0.998 0.000
H47.6 Disorders of visual cortex
0.002 0.998 0.000
H47.5 Disorders of other visual pathways
0.002 0.998 0.000
H47.4 Disorders of optic chiasm
0.002 0.998 0.000
E34.3 Short stature, not elsewhere classified
0.002 0.998 0.000
H43.9 Disorder of vitreous body, unspecified
0.000 0.998 0.002
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
0.000 0.998 0.002
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema
0.000 0.998 0.002
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease
0.000 0.998 0.002
G13.0 Paraneoplastic neuromyopathy and neuropathy
0.000 0.998 0.002
F05.1 Delirium superimposed on dementia
0.002 0.998 0.000
E26.8 Other hyperaldosteronism
0.002 0.998 0.000
E26.1 Secondary hyperaldosteronism
0.002 0.998 0.000
E20-E35 Disorders of other endocrine glands
0.002 0.998 0.000
D61.9 Aplastic anaemia, unspecified
0.002 0.998 0.000
E34.5 Androgen resistance syndrome
0.002 0.998 0.000
E34.4 Constitutional tall stature
0.002 0.998 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.002 0.998 0.000
E34.1 Other hypersecretion of intestinal hormones
0.002 0.998 0.000
H43.2 Crystalline deposits in vitreous body
0.000 0.998 0.002
K90.9 Intestinal malabsorption, unspecified
0.000 0.998 0.002
T21.2 Burn of second degree of trunk
0.002 0.998 0.000
Z48 Other surgical follow-up care
0.002 0.998 0.000
T18.9 Foreign body in alimentary tract, part unspecified
0.002 0.998 0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.000 0.998 0.002
H43.0 Vitreous prolapse
0.000 0.998 0.002
F05.0 Delirium not superimposed on dementia, so described
0.002 0.998 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.002 0.998 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.002 0.998 0.000
E23.1 Drug-induced hypopituitarism
0.002 0.998 0.000
H34.8 Other retinal vascular occlusions
0.002 0.998 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.002 0.998 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.002 0.998 0.000
E23.6 Other disorders of pituitary gland
0.002 0.998 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.002 0.998 0.000
H74.0 Tympanosclerosis
0.002 0.998 0.000
I87.2 Venous insufficiency (chronic) (peripheral)
0.002 0.998 0.000
N70.1 Chronic salpingitis and oophoritis
0.002 0.998 0.000
R25 Abnormal involuntary movements
0.002 0.998 0.000
E23.2 Diabetes insipidus
0.002 0.998 0.000
X59.2 School, other institution and public administrative area
0.002 0.998 0.000
K76 Other diseases of liver
0.000 0.998 0.002
N30.9 Cystitis, unspecified
0.000 0.998 0.002
S51.7 Multiple open wounds of forearm
0.002 0.998 0.000
E29 Testicular dysfunction
0.002 0.998 0.000
X78 Intentional self-harm by sharp object
0.002 0.998 0.000
N00-N08 Glomerular diseases
0.002 0.998 0.000
J39.2 Other diseases of pharynx
0.002 0.998 0.000
M23.4 Loose body in knee
0.002 0.998 0.000
E31 Polyglandular dysfunction
0.002 0.998 0.000
N70 Salpingitis and oophoritis
0.002 0.998 0.000
J38.2 Nodules of vocal cords
0.000 0.998 0.002
R23.8 Other and unspecified skin changes
0.002 0.998 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.002 0.998 0.000
E32 Diseases of thymus
0.002 0.998 0.000
E30 Disorders of puberty, not elsewhere classified
0.002 0.998 0.000
M13.97 Arthritis, unspecified (Ankle and foot)
0.002 0.998 0.000
T18.1 Foreign body in oesophagus
0.002 0.998 0.000
T75.1 Drowning and nonfatal submersion
0.002 0.998 0.000
X78.2 School, other institution and public administrative area
0.002 0.998 0.000
E25 Adrenogenital disorders
0.002 0.998 0.000
E20.1 Pseudohypoparathyroidism
0.002 0.998 0.000
H53.8 Other visual disturbances
0.000 0.998 0.002
T24.2 Burn of second degree of hip and lower limb, except ankle and foot
0.002 0.998 0.000
E20 Hypoparathyroidism
0.002 0.998 0.000
M23.43 Loose body in knee-Med lig/oth men
0.002 0.998 0.000
T91.3 Sequelae of injury of spinal cord
0.002 0.998 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.002 0.998 0.000
E27.2 Addisonian crisis
0.002 0.998 0.000
E27 Other disorders of adrenal gland
0.002 0.998 0.000
T91 Sequelae of injuries of neck and trunk
0.002 0.998 0.000
I84.1 Internal haemorrhoids with other complications
0.002 0.998 0.000
C18.6 Descending colon
0.002 0.998 0.000
K76.1 Chronic passive congestion of liver
0.000 0.998 0.002
N04.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
Q87.4 Marfan's syndrome
0.000 0.998 0.002
V48.4 Person injured while boarding or alighting
0.002 0.998 0.000
K74.5 Biliary cirrhosis, unspecified
0.002 0.998 0.000
Z48.8 Other specified surgical follow-up care
0.002 0.998 0.000
F03 Unspecified dementia
0.002 0.998 0.000
N04 Nephrotic syndrome
0.002 0.998 0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)
0.002 0.998 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.998 0.002
N23 Unspecified renal colic
0.002 0.998 0.000
E21.2 Other hyperparathyroidism
0.002 0.998 0.000
R25.0 Abnormal head movements
0.002 0.998 0.000
W17.4 Street and highway
0.000 0.998 0.002
E29.1 Testicular hypofunction
0.002 0.998 0.000
K76.5 Hepatic veno-occlusive disease
0.000 0.998 0.001
K76.4 Peliosis hepatis
0.000 0.998 0.001
K76.3 Infarction of liver
0.000 0.998 0.002
K76.2 Central haemorrhagic necrosis of liver
0.000 0.998 0.001
M23.46 Loose body in knee-O/unsp lat men
0.002 0.998 0.000
M23.44 Loose body in knee-Lat lig/ant men
0.002 0.998 0.000
E31.0 Autoimmune polyglandular failure
0.001 0.998 0.000
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level
0.002 0.998 0.000
E29.9 Testicular dysfunction, unspecified
0.001 0.998 0.000
E29.8 Other testicular dysfunction
0.001 0.998 0.000
E29.0 Testicular hyperfunction
0.001 0.998 0.000
X78.9 Unspecified place
0.001 0.998 0.000
X78.8 Other specified place
0.001 0.998 0.000
X78.7 Farm
0.001 0.998 0.000
X78.6 Industrial and construction area
0.001 0.998 0.000
X78.5 Trade and service area
0.001 0.998 0.000
X78.4 Street and highway
0.001 0.998 0.000
X78.3 Sports and athletics area
0.001 0.998 0.000
X78.1 Residential institution
0.001 0.998 0.000
Z73.3 Stress, not elsewhere classified
0.000 0.998 0.002
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)
0.000 0.998 0.002
E21.4 Other specified disorders of parathyroid gland
0.001 0.998 0.000
E31.9 Polyglandular dysfunction, unspecified
0.001 0.998 0.000
E31.8 Other polyglandular dysfunction
0.001 0.998 0.000
E31.1 Polyglandular hyperfunction
0.001 0.998 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.001 0.998 0.000
N06 Isolated proteinuria with specified morphological lesion
0.001 0.998 0.000
N01 Rapidly progressive nephritic syndrome
0.001 0.998 0.000
N00 Acute nephritic syndrome
0.001 0.998 0.000
T21 Burn and corrosion of trunk
0.002 0.998 0.000
M23.47 Loose body in knee-Capsular lig
0.001 0.998 0.000
M23.45 Loose body in knee-Pst hrn lat men
0.001 0.998 0.000
M23.42 Loose body in knee-Pst lig/hrn men
0.001 0.998 0.000
N04.8 Other
0.001 0.998 0.000
M23.40 Loose body in knee-Mult sites
0.001 0.998 0.000
E30.9 Disorder of puberty, unspecified
0.001 0.998 0.000
E30.8 Other disorders of puberty
0.001 0.998 0.000
E30.1 Precocious puberty
0.001 0.998 0.000
E30.0 Delayed puberty
0.001 0.998 0.000
E32.9 Disease of thymus, unspecified
0.001 0.998 0.000
E32.8 Other diseases of thymus
0.001 0.998 0.000
E32.1 Abscess of thymus
0.001 0.998 0.000
E32.0 Persistent hyperplasia of thymus
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.